HOME >> BIOLOGY >> NEWS
LDL receptor reduces LDL production, removes cholesterol from blood

MADISON -- A cell membrane protein thought mainly to bind "bad" cholesterol and remove it from circulation also plays a major role in reducing the production of that cholesterol, according to a study published this February in the Journal of Clinical Investigation.

The University of Wisconsin-Madison study provides new insights into the nature of lipoprotein overproduction in people with familial hypercholesterolemia (FH), an inherited disease that affects one in 500 people. The research also explains how statins, a class of medications taken by several million Americans, work to lower blood cholesterol levels.

Low-density lipoprotein (LDL) carries cholesterol to other cells in the body that need it. People whose blood levels of LDL -- the "bad" cholesterol -- are too high have an increased risk of heart disease. Individuals with FH have extremely high levels of LDL and are at high risk for heart attacks at an early age.

"In the 1970s researchers discovered that the LDL receptor is responsible for removing most of the cholesterol from blood," according to Alan Attie, a biochemist in the UW-Madison College of Agricultural and Life Sciences. "They showed that a mutation in the gene that codes for the LDL receptor causes FH. Most people thought that the receptor's major function was to clear LDL from blood."

However, scientists later found that people with FH have high LDL levels not only because they clear it from their blood too slowly, but also because they produce too much, Attie says. "Ours is the first study that explains the paradox of why people with FH produce too much LDL," he says. "We showed that functional LDL receptors increase the degradation of apolipoprotein B inside liver cells."

Apolipoprotein B (apoB) is the major protein component of very low-density lipoprotein, which is made by liver cells and converted to LDL in the blood. The rate of apoB production in liver cells -- and thus LDL production -- is determined by how much a
'"/>

Contact: Alan Attie
attie@biochem.wisc.edu
608-262-1372
University of Wisconsin-Madison
4-Apr-2000


Page: 1 2 3

Related biology news :

1. Ovarian cancer sheds tumor suppression with loss of estrogen receptor
2. Alterations in vitamin D receptor gene increase prostate, breast cancer risk
3. Two-pronged attack targeting EGF receptor hinders cancer cell growth
4. Tamoxifen stimulates breast cancer growth following alteration of estrogen receptor
5. Dioxin-receptor network identified
6. Inhibition of insulin-like growth factor receptor-1 as promising anticancer therapeutic
7. Scientists at Scripps Research Institute describe structure of receptor on surface of 1918 flu virus
8. Activation of receptor ups development of precancerous intestinal polyps
9. Researchers find an association between alcohol dependence and the GABAA receptor gene GABRG3
10. The dopamine receptor D1 gene and ADHD: A piece of the genetic puzzle?
11. Estrogen receptor-a disruption and vasodilation in coronary arteries

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/14/2019)... ... November 13, 2019 , ... ... Robert Peterson, RAC , a regulatory affairs and program management executive with more ... medical device industries, has joined the firm as an Expert Consultant. , ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... proposals from nonprofit U.S. universities and research institutions for its Instrumentation Grant ... of up to $1.2 million per site for the acquisition of instrumentation, development ...
(Date:11/7/2019)... ... November 07, 2019 , ... R3 Stem Cell is now offering ... rest of 2019. The code to use during checkout is FIFTYOFF and applies to ... the nation’s leader in regenerative therapies with over 12,000 successful stem cell procedures performed ...
Breaking Biology News(10 mins):
(Date:11/5/2019)... ... 05, 2019 , ... Focal Healthcare , an innovator ... Fusion Bx 2.0 prostate fusion biopsy solution. By combining information from multiparametric MRI ... give urologists across Europe the ability to perform targeted transrectal and transperineal prostate ...
(Date:11/2/2019)... ... October 31, 2019 , ... ... pharma artificial intelligence pioneer tellic. drug360 brings tellic’s expertise in biomedical language ... allows researchers to quickly uncover relationships between genes, diseases, variants, phenotypes, and other ...
(Date:10/29/2019)... ... October 29, 2019 , ... ... its Silver sponsorship and cold chain validation workshop at the Biomanufacturing World Summit ... San Diego, California. , The Biomanufacturing World Summit brings together pharmaceutical ...
(Date:10/22/2019)... ... ... Catalent, a global leader in clinical supply services, today announced that Ann ... a panel session titled “Cell and Gene Therapy Logistics” at the upcoming Health and ... Oct. 28-30, 2019. , The panel session, on Wednesday, Oct. 30 at 8:30 a.m., ...
Breaking Biology Technology:
Cached News: